Last quarter (Q4 2023), Avalo Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Avalo Therapeutics's net income was $―. See Avalo Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 1.35M	$ 1.92M	$ 18.05M	$ 5.40M	$ 6.70M	$ 6.75M
Cost of Revenue	$ 404.00K	$ 1.28M	$ 3.43M	$ 3.04M	$ 300.00K	$ -566.52K
Gross Profit	$ -152.00K	$ 640.00K	$ 14.62M	$ 2.36M	$ 6.40M	$ 7.32M
Operating Expense	$ 19.54M	$ 24.08M	$ 52.06M	$ 84.49M	$ 53.69M	$ 24.71M
Operating Income	$ -19.69M	$ -27.35M	$ -37.44M	$ -82.13M	$ -47.29M	$ -17.39M
Net Non Operating Interest Income Expense	$ -3.50M	$ -3.42M	$ -4.17M	$ -2.39M	$ 49.00K	$ 121.33K
Other Income Expense	$ 163.00K	$ 762.00K	$ 20.00K	$ 20.00K	$ -19.93M	$ 1.28M
Pretax Income	$ -23.35M	$ -31.53M	$ -41.63M	$ -84.55M	$ -67.18M	$ -15.99M
Tax Provision	$ 23.00K	$ 14.00K	$ 28.00K	$ -196.00K	$ -2.79M	$ 280.32K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -23.38M	$ -31.54M	$ -41.66M	$ -84.35M	$ -57.64M	$ -12.06M
Basic EPS	$ -1.55	$ -114.00	$ -1.06K	$ -59.76	$ -0.86	$ -0.28
Diluted EPS	$ -1.55	$ -114.00	$ -1.06K	$ -59.76	$ -0.86	$ -0.28
Basic Average Shares	$ 72.46M	$ 277.73K	$ 39.20K	$ 1.41M	$ 66.69M	$ 42.88M
Diluted Average Shares	$ 72.46M	$ 277.73K	$ 39.20K	$ 1.41M	$ 66.69M	$ 42.88M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 24.27M	$ 25.37M	$ 55.49M	$ 87.53M	$ 53.99M	$ 24.14M
Net Income From Continuing And Discontinued Operation	$ -23.38M	$ -31.54M	$ -41.66M	$ -84.35M	$ -63.50M	$ -16.07M
Normalized Income	$ -4.28M	$ -21.00M	-	-	$ -44.90M	$ -17.23M
Interest Expense	-	-	-	-	-	-
EBIT	$ -31.53M	$ -31.53M	$ -41.63M	$ -84.55M	$ -47.29M	$ -17.39M
EBITDA	$ -29.54M	$ -29.54M	$ -40.08M	$ -82.09M	$ -45.45M	$ -13.51M

Currency in USD

Avalo Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing